Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation

[1]  H. Einsele,et al.  Characterization of lineage‐specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse , 2000, British journal of haematology.

[2]  A. de Man,et al.  Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T‐cell‐depleted bone marrow transplantation and after donor leucocyte infusion , 2000, British journal of haematology.

[3]  S. Bigner,et al.  Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit. , 2000, American journal of clinical pathology.

[4]  R. Storb,et al.  Mixed chimerism: preclinical studies and clinical applications. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  C. Figdor,et al.  A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia , 1999, The Journal of experimental medicine.

[6]  J. Briones,et al.  High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. , 1998, Experimental hematology.

[7]  H. Einsele,et al.  Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT , 1998, Bone Marrow Transplantation.

[8]  R. Miniero,et al.  Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation , 1997, Bone Marrow Transplantation.

[9]  J. Hancock,et al.  Same‐day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation , 1997, British journal of haematology.

[10]  F. Preijers,et al.  Outcome of transplantation for standard‐risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen , 1997, British journal of haematology.

[11]  T. Klingebiel,et al.  Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse? , 1997, Bone Marrow Transplantation.

[12]  S. Dermime,et al.  Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.

[13]  A. de Man,et al.  Flow cytometric method for the routine follow‐up of red cell populations after bone marrow transplantation , 1997, British journal of haematology.

[14]  T. Klingebiel,et al.  Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children , 1997, Bone Marrow Transplantation.

[15]  M. Velasco,et al.  Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. , 1996, Bone marrow transplantation.

[16]  J. Wang-Rodriguez,et al.  Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats , 1996, American journal of hematology.

[17]  B. Chapuis,et al.  Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. , 1996, Blood.

[18]  J. Tanzer,et al.  Monitoring and prognostic evaluation of sex-mismatched bone marrow transplantation by competitive PCR on Y chromosome sequences. , 1996, Bone marrow transplantation.

[19]  M. Potter,et al.  Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. , 1996, Blood.

[20]  A. Elmaagacli,et al.  Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia. , 1995, Bone marrow transplantation.

[21]  M. Caligiuri,et al.  Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation. , 1995, Bone marrow transplantation.

[22]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[23]  G. Socié,et al.  Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era. , 1995, Leukemia research.

[24]  S. Mackinnon,et al.  Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? , 1995, Bone marrow transplantation.

[25]  C. McFarland,et al.  Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. , 1995, Blood.

[26]  B. Chapuis,et al.  Application of a polymorphic Y microsatellite to the detection of post bone marrow transplantation chimaerism , 1995, British journal of haematology.

[27]  M. V. van Tol,et al.  Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. , 1994, Blood.

[28]  J. Bourhis,et al.  Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non−T-cell−depleted bone marrow transplantation , 1994 .

[29]  J. Gribben,et al.  Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. , 1994, Blood.

[30]  L. Barnett,et al.  Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. , 1994, Blood.

[31]  J. Wijnen,et al.  Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. , 1993, Blood.

[32]  E. Trabetti,et al.  In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMT. , 1993, Bone marrow transplantation.

[33]  N. Schmitz,et al.  Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms. , 1993, Leukemia.

[34]  M. Lawler,et al.  Mixed chimaerism; detection and significance following BMT. , 1993, Bone marrow transplantation.

[35]  F. Lacombe,et al.  Mixed chimerism after sex-mismatched allogeneic BMT: evaluation of two molecular techniques. , 1993, Bone marrow transplantation.

[36]  P. Martin.  Determinants of engraftment after allogeneic marrow transplantation. , 1992, Blood.

[37]  A. de Man,et al.  Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow. , 1992, Bone marrow transplantation.

[38]  H. Deeg,et al.  Changing trends in marrow transplantation for aplastic anemia. , 1992, Bone marrow transplantation.

[39]  D. Blaise,et al.  Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. , 1991, Blood.

[40]  P. Humphries,et al.  Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction , 1991 .

[41]  S. Forman,et al.  Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation , 1991 .

[42]  D. Smeets,et al.  Comparison of chimerism of red cells with that of granulocytes, T-lymphocytes, and bone marrow cells in recipients of bone marrow grafts depleted of lymphocytes using counterflow centrifugation. , 1991, Leukemia & lymphoma.

[43]  K. Offit,et al.  Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. , 1990, Blood.

[44]  J. Raemaekers,et al.  Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. , 1990, Blood.

[45]  K. Anderson,et al.  Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. , 1990, Blood.

[46]  B. Bär,et al.  Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analysed with antibody‐coated fluorescent microspheres , 1989, British journal of haematology.

[47]  D. Smeets,et al.  Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. , 1989, Blood.

[48]  B. A. Dijk,et al.  A Fluorescent Microsphere Method for the Investigation of Erythrocyte Chimaerism after Allogeneic Bone Marrow Transplantation Using Antigenic Differences , 1988, Vox sanguinis.

[49]  C. Haanen,et al.  A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials. , 1988, Experimental hematology.

[50]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[51]  Knowlton,et al.  Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. , 1987, Blood.

[52]  D. Arthur,et al.  Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. , 1985, Blood.

[53]  M. Trigg,et al.  Relapse of host leukemic lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the "graft versus leukemia" effect. , 1985, Experimental hematology.

[54]  C. Haanen,et al.  BONE MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE‐DEPLETED ALLOGENEIC BONE MARROW USING COUNTERFLOW CENTRIFUGATION , 1984, Transplantation.

[55]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[56]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.